WO2006067328A3 - Use of benzodiazepine receptor ligands for combating signs of ageing - Google Patents

Use of benzodiazepine receptor ligands for combating signs of ageing Download PDF

Info

Publication number
WO2006067328A3
WO2006067328A3 PCT/FR2005/003199 FR2005003199W WO2006067328A3 WO 2006067328 A3 WO2006067328 A3 WO 2006067328A3 FR 2005003199 W FR2005003199 W FR 2005003199W WO 2006067328 A3 WO2006067328 A3 WO 2006067328A3
Authority
WO
WIPO (PCT)
Prior art keywords
ageing
receptor ligands
benzodiazepine receptor
combating signs
signs
Prior art date
Application number
PCT/FR2005/003199
Other languages
French (fr)
Other versions
WO2006067328A2 (en
Inventor
Isabelle Besne
Maria Dalko
Original Assignee
Oreal
Isabelle Besne
Maria Dalko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0453083A external-priority patent/FR2879451B1/en
Application filed by Oreal, Isabelle Besne, Maria Dalko filed Critical Oreal
Priority to JP2007546127A priority Critical patent/JP2008524177A/en
Priority to BRPI0517216-0A priority patent/BRPI0517216A/en
Priority to EP05850548A priority patent/EP1830796A2/en
Priority to CA002591606A priority patent/CA2591606A1/en
Priority to US11/722,322 priority patent/US20080194620A1/en
Publication of WO2006067328A2 publication Critical patent/WO2006067328A2/en
Publication of WO2006067328A3 publication Critical patent/WO2006067328A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Abstract

The invention relates to the cosmetic use of at least one benzodiazepine peripheral receptor antagonist in a composition containing a physiologically acceptable medium, as an agent for reducing or preventing cutaneous signs of ageing.
PCT/FR2005/003199 2004-12-20 2005-12-20 Use of benzodiazepine receptor ligands for combating signs of ageing WO2006067328A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2007546127A JP2008524177A (en) 2004-12-20 2005-12-20 Use of benzodiazepine receptor ligands to combat aging signs
BRPI0517216-0A BRPI0517216A (en) 2004-12-20 2005-12-20 cosmetic use of at least one peripheral benzodizepine receptor antagonist and cosmetic process to combat wrinkles
EP05850548A EP1830796A2 (en) 2004-12-20 2005-12-20 Use of benzodiazepine receptor ligands for combating signs of ageing
CA002591606A CA2591606A1 (en) 2004-12-20 2005-12-20 Use of benzodiazepine receptor ligands for combating signs of ageing
US11/722,322 US20080194620A1 (en) 2004-12-20 2005-12-20 Use of Benzodiazepine Receptor Ligands For Combating Signs of Ageing

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0453083 2004-12-20
FR0453083A FR2879451B1 (en) 2004-12-20 2004-12-20 USE OF BENZODIAZEPINE RECEPTOR LIGANDS TO FIGHT AGING SIGNS
US64142505P 2005-01-06 2005-01-06
US60/641,425 2005-01-06

Publications (2)

Publication Number Publication Date
WO2006067328A2 WO2006067328A2 (en) 2006-06-29
WO2006067328A3 true WO2006067328A3 (en) 2007-03-29

Family

ID=36487059

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/003199 WO2006067328A2 (en) 2004-12-20 2005-12-20 Use of benzodiazepine receptor ligands for combating signs of ageing

Country Status (6)

Country Link
US (1) US20080194620A1 (en)
EP (1) EP1830796A2 (en)
JP (1) JP2008524177A (en)
BR (1) BRPI0517216A (en)
CA (1) CA2591606A1 (en)
WO (1) WO2006067328A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4362457B2 (en) * 2005-04-26 2009-11-11 独立行政法人科学技術振興機構 Neuropathic pain treatment
FR3018191B1 (en) * 2014-03-10 2018-01-12 Lucas Meyer Cosmetics COSMETIC USES OF SWERTIAMARIN

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976559A (en) * 1994-09-30 1999-11-02 L'oreal Compositions and methods for treating wrinkles and/or fine lines of the skin
WO2001082877A2 (en) * 2000-05-04 2001-11-08 Basf Aktiengesellschaft Use of parp inhibitors in cosmetic preparations
FR2811897A1 (en) * 2000-07-24 2002-01-25 Sanofi Synthelabo Treatment of diseases associated with peripheral benzodiazepine receptor dysfunction, e.g. peripheral neuropathy, cardiac insufficiency or cancer, using pyridazino(4,5-b)indole-1-acetamide derivatives
US6767533B1 (en) * 1998-11-17 2004-07-27 Sanofi-Synthelabo Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
EP1475368A1 (en) * 2002-02-14 2004-11-10 Ono Pharmaceutical Co., Ltd. N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2736829B1 (en) * 1995-07-20 1997-09-12 Oreal COMPOSITION FOR FIGHTING AGAINST SPOTS AND / OR AGING OF THE SKIN, USES THEREOF

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976559A (en) * 1994-09-30 1999-11-02 L'oreal Compositions and methods for treating wrinkles and/or fine lines of the skin
US6767533B1 (en) * 1998-11-17 2004-07-27 Sanofi-Synthelabo Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
WO2001082877A2 (en) * 2000-05-04 2001-11-08 Basf Aktiengesellschaft Use of parp inhibitors in cosmetic preparations
FR2811897A1 (en) * 2000-07-24 2002-01-25 Sanofi Synthelabo Treatment of diseases associated with peripheral benzodiazepine receptor dysfunction, e.g. peripheral neuropathy, cardiac insufficiency or cancer, using pyridazino(4,5-b)indole-1-acetamide derivatives
EP1475368A1 (en) * 2002-02-14 2004-11-10 Ono Pharmaceutical Co., Ltd. N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient

Also Published As

Publication number Publication date
BRPI0517216A (en) 2008-09-30
EP1830796A2 (en) 2007-09-12
CA2591606A1 (en) 2006-06-29
JP2008524177A (en) 2008-07-10
WO2006067328A2 (en) 2006-06-29
US20080194620A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
ZA200610040B (en) Substituted indazoles, compositions containing same, preparation use
PL1792927T3 (en) Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
IL174215A0 (en) Benzimidazole derivatives, compositions containing them preparation thereof and uses thereof
AU2003298040A1 (en) Catalyst formulation for hydrogenation
AU2003293328A8 (en) Protected, hidden emergency boot directory
WO2009042114A3 (en) Phenazine derivatives and uses thereof
IL175300A0 (en) Indirubin-type compounds, compositions, and methods for their use
IL173807A0 (en) Amphiphilic antioxidant compounds, mitoquinone derivatives and pharmaceutical compositions containing the same
IL172027A0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ZA200606606B (en) Substituted Azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
EP1819323A4 (en) Pharmaceutical composition containing an anti-nucleating agent
EP2332526A3 (en) Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
EP1705989B8 (en) Substituted arylpyrazoles as parasiticidal agents
HK1104823A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
WO2006069159A3 (en) Pharmaceutical compositions comprising amorphous benzimidazole compounds
EP1797078A4 (en) Compounds, compositions containing them, preparation thereof and uses thereof iii
AU2003282156A1 (en) Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type ii diabetes
EP1797077A4 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
IL181216A (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
WO2006067328A3 (en) Use of benzodiazepine receptor ligands for combating signs of ageing
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds
WO2006055663A3 (en) The use of novel antibacterial compounds
AU2003303312A1 (en) Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
EP1797074A4 (en) Compounds, compositions containing them, preparation thereof and uses thereof iiii

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005850548

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2591606

Country of ref document: CA

Ref document number: 2007546127

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2005850548

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0517216

Country of ref document: BR